| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/04/1996 | WO1996020206A1 Secreted human fas antigen |
| 07/04/1996 | WO1996020014A1 Viral vector complexes having adapters of predefined valence |
| 07/04/1996 | WO1996020013A1 Improvements in or relating to endometrial function |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | WO1996011664A3 NSK2 a muscle receptor tyrosine kinase |
| 07/04/1996 | WO1995022598A3 Corn plants and products with improved oil composition |
| 07/04/1996 | DE4447015A1 Isolation and purificn. of nucleic acids |
| 07/04/1996 | DE4436664A1 Cells that stably express specific adeno-associated virus Rep proteins |
| 07/04/1996 | DE19521980C1 Transgenic animal deficient in acid sphingomyelinase |
| 07/04/1996 | CA2211038A1 Secreted human fas antigen |
| 07/04/1996 | CA2208794A1 Nucleic acid sequence detection employing amplification probes |
| 07/04/1996 | CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208446A1 Improvements in or relating to endometrial function |
| 07/04/1996 | CA2208329A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | CA2208072A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | CA2207952A1 Automated dna sequencing |
| 07/04/1996 | CA2207820A1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/04/1996 | CA2182946A1 Human phosphodiesterase type ivc, and its production and use |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719863A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same |
| 07/03/1996 | EP0719862A2 A regulatory factor for expression of nitrilase gene and a gene thereof |
| 07/03/1996 | EP0719861A1 Nucleic sequences from the genome of Salmonella Typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
| 07/03/1996 | EP0719859A1 Anti-alpha V-integrin monoclonal antibody |
| 07/03/1996 | EP0719858A2 Myeloma cell line expressing recombinant human thyroid stimulating hormone receptor |
| 07/03/1996 | EP0719792A2 Somatotropin variants |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719342A1 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
| 07/03/1996 | EP0719341A1 Regulation of senescence |
| 07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
| 07/03/1996 | EP0719339A1 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 07/03/1996 | EP0719338A1 Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants and the modified starch obtainable therefrom |
| 07/03/1996 | EP0719337A1 PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0719335A1 Hybrid toxin |
| 07/03/1996 | EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 07/03/1996 | EP0719333A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 07/03/1996 | EP0719332A1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719330A1 Protocadherin proteins and their uses |
| 07/03/1996 | EP0719329A1 Human receptor h4-1bb |
| 07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719284A1 Improvements in or relating to haemoglobin |
| 07/03/1996 | EP0719272A1 Pyrimidine derivatives for labeled binding partners |
| 07/03/1996 | EP0719265A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives |
| 07/03/1996 | EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/03/1996 | EP0719080A1 Mutant dwarfism gene of petunia |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0639223B1 Microfabricated sperm handling devices |
| 07/03/1996 | EP0515433B1 Recombinant poxvirus internal cores |
| 07/03/1996 | EP0502976B1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 07/03/1996 | EP0441955B1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 07/03/1996 | EP0417160B1 Method for hla dp typing |
| 07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
| 07/03/1996 | CN1125982A Methods of typing hepatitis C virus and reagents for use therein |
| 07/02/1996 | US5532347 DNA encoding α melanocyte stimulating hormone receptor |
| 07/02/1996 | US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 07/02/1996 | US5532340 Tumor suppressor protein PRB2, related gene products, and DNA encoding therefor |
| 07/02/1996 | US5532339 Fusion protein between human macif and a heterologous pi anchor domain |
| 07/02/1996 | US5532337 Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments |
| 07/02/1996 | US5532220 Of mammarian cancer cells lacking endogeneous protein; introducing suppressor gene encoding protein into cells |
| 07/02/1996 | US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof |
| 07/02/1996 | US5532169 Quantitating concentration of peptides in body fluids and collagen telopeptides with hydroxylysyl pyridoline crosslinking |
| 07/02/1996 | US5532159 Antitumor agents; hybridomas |
| 07/02/1996 | US5532158 Dna construct of gene fragments for genomic dna |
| 07/02/1996 | US5532154 Mutated alpha virus |
| 07/02/1996 | US5532153 Method for cloning and producing the SacI restriction endonuclease |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5532151 Purified isolated polynucleotide encoding mammalian grk6 enzyme; dna vector; rna transcript of genomic dna; host cell stably transformed or transfected with the dna to allow expression in cell of grk6 enzyme with kinase activity; |
| 07/02/1996 | US5532146 Method for rendering ligase-based amplification products unamplifiable |
| 07/02/1996 | US5532145 Purification of polymerase |
| 07/02/1996 | US5532143 Isolated DNA molecules for intergration site independent gene expression in mammalian host cells |
| 07/02/1996 | US5532142 Proteins for genetic engineering with dna using proteinase |
| 07/02/1996 | US5532133 Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays |
| 07/02/1996 | US5532130 Hybridizing single strand dna for antisense oligonucleotides |
| 07/02/1996 | US5532129 Self-organizing molecular photonic structures based on chromophore- and fluorophore-containing polynucleotides and methods of their use |
| 07/02/1996 | US5532127 Assay for 1-CAM related protein expression |
| 07/02/1996 | US5532124 Genetically engineered bacteria to identify and produce medically important agents |
| 07/02/1996 | US5532123 Receptor-type phosphotyrosine phosphatase-γ |
| 07/02/1996 | US5532108 Gene deleted in colorectal cancer of humans |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 07/02/1996 | CA2059129C Encapsulation process |
| 07/01/1996 | CA2166371A1 Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease |
| 06/27/1996 | WO1996019587A2 Methods of immobilizing oligonucleotides to solid support materials and methods of using support bound oligonucleotides |
| 06/27/1996 | WO1996019586A1 Method and composition for internal identification of samples |
| 06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | WO1996019582A1 Microbially derived rennin having enhanced milk clotting activity and method of producing same |
| 06/27/1996 | WO1996019581A1 Dna molecules coding for debranching enzymes derived from plants |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019579A1 Nuclear protein serine/threonine kinases |
| 06/27/1996 | WO1996019577A1 Vs ribozymes |